HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

Acute catarrhal tonsillitis — Clinical Guidelines

Overview

Acute catarrhal tonsillitis is an inflammatory condition characterized by the acute onset of symptoms such as sore throat, fever, and tonsillar exudates, often due to viral or bacterial pathogens, particularly Group A Streptococcus. This condition is prevalent among children and young adults but can affect individuals of any age. Given its potential to cause significant discomfort and complications if untreated, accurate diagnosis and timely management are crucial in day-to-day practice to prevent complications like peritonsillar abscess or rheumatic fever 1 2.

Pathophysiology

Acute catarrhal tonsillitis typically arises from an infectious process where pathogens, predominantly viruses initially and sometimes transitioning to bacteria like Group A Streptococcus, invade the tonsillar tissue. The host immune response triggers inflammation characterized by increased vascular permeability, leukocyte infiltration, and the release of pro-inflammatory cytokines such as interleukin-1 (IL-1) and tumor necrosis factor-alpha (TNF-α). These mediators contribute to the classic symptoms including sore throat, fever, and swelling of the tonsils. The inflammatory cascade also leads to the formation of tonsillar exudates and may predispose patients to secondary complications if not adequately managed 1 2.

Epidemiology

The incidence of acute catarrhal tonsillitis varies geographically and seasonally, with higher prevalence observed in colder months and among school-aged children. Studies suggest an annual incidence rate ranging from 10% to 20% in pediatric populations, with peaks in children aged 5 to 15 years. Gender distribution is relatively equal, though some regional variations exist. Risk factors include close contact with infected individuals, poor hygiene, and underlying immune deficiencies. Trends indicate a shift towards viral etiologies in recent years, possibly due to improved antibiotic stewardship and changes in circulating pathogens 1 2.

Clinical Presentation

The typical presentation of acute catarrhal tonsillitis includes a sudden onset of sore throat, fever (often above 38°C), and visible tonsillar swelling with erythema and exudates. Patients may also exhibit halitosis, difficulty swallowing (dysphagia), headache, and generalized malaise. Atypical presentations can include abdominal pain mimicking appendicitis or atypical neck swelling that might suggest peritonsillar abscess. Red-flag features warranting urgent evaluation include severe neck stiffness, difficulty breathing, drooling, and signs of systemic toxicity such as altered mental status or high fever unresponsive to antipyretics 1 2.

Diagnosis

The diagnosis of acute catarrhal tonsillitis is primarily clinical, guided by the presence of characteristic symptoms and signs. Specific diagnostic criteria include:

Clinical Symptoms: Sore throat, fever, and tonsillar swelling with erythema.

Physical Examination: Presence of tonsillar exudates, enlarged and tender cervical lymph nodes.

Laboratory Tests: Throat swab for rapid antigen detection tests (RADT) or throat culture to identify Group A Streptococcus, particularly if bacterial etiology is suspected. C-reactive protein (CRP) levels may be elevated but are not specific.

Differential Diagnosis: Distinguishing from viral pharyngitis, peritonsillar abscess, and infectious mononucleosis (monospot test can help rule out the latter).

Differential Diagnosis:

Viral Pharyngitis: Typically milder, less exudative, and without significant lymphadenopathy.

Peritonsillar Abscess: Presence of trismus, drooling, and asymmetric tonsillar swelling.

Infectious Mononucleosis: Enlarged spleen, atypical lymphocytosis, and positive monospot test 1 2.

Management

Initial Management

Symptomatic Relief:

- Antipyretics: Paracetamol (15 mg/kg every 6-8 hours) or ibuprofen (5-10 mg/kg every 6-8 hours) for fever and pain relief 1 2. - Hydration: Encourage fluid intake to prevent dehydration. - Rest: Adequate rest to support recovery.

Antibiotic Therapy (if indicated)

Bacterial Etiology:

- First-Line: Amoxicillin (80-90 mg/kg/day in divided doses for 10 days) for Group A Streptococcus 1 2. - Alternative: Clavulanate added to amoxicillin if resistance is suspected or in severe cases.

Analgesia for Post-Tonsillectomy Pain (if applicable)

Non-Steroidal Anti-Inflammatory Drugs (NSAIDs):

- Intranasal Diclofenac: 1 mg/kg (max 50 mg) every 8-12 hours 1. - Intranasal Ibuprofen: 5-10 mg/kg (max 400 mg) every 8-12 hours 1. - Ketoprofen: 2 mg/kg (max 150 mg) intravenously over 30 minutes, repeated after 12 hours 5. - Diclofenac: 75 mg intravenously, repeated after 12 hours 5. - Tramadol: 1 mg/kg (max 100 mg) intravenously, repeated as needed 3.

COX-2 Inhibitors:

- Rofecoxib: 0.625 mg/kg (max 50 mg) orally, if NSAID contraindications exist 2.

Opioids:

- Rescue Analgesia: Fentanyl via patient-controlled analgesia (PCA) for breakthrough pain 3 4.

Monitoring and Follow-Up

Vital Signs: Monitor temperature, pulse, and respiratory rate.

Pain Assessment: Regularly assess pain levels using validated scales like VAS.

Hydration Status: Ensure adequate fluid intake.

Follow-Up: Reassess within 24-48 hours, especially if symptoms persist or worsen 1 2.

Complications

Acute Complications: Peritonsillar abscess, dehydration, airway obstruction.

Long-Term Complications: Recurrent tonsillitis, post-streptococcal glomerulonephritis, rheumatic fever.

Management Triggers: Persistent high fever, severe pain unresponsive to analgesics, signs of airway compromise necessitate urgent referral to otolaryngology 1 2.

Prognosis & Follow-Up

The prognosis for acute catarrhal tonsillitis is generally good with appropriate treatment, with most patients recovering within 7-10 days. Recurrent episodes may indicate the need for tonsillectomy. Prognostic indicators include prompt initiation of appropriate antibiotics for bacterial causes and effective pain management. Follow-up appointments should be scheduled to monitor recovery and address any complications. Regular follow-up intervals are typically every 1-2 weeks initially, tapering off as symptoms resolve 1 2.

Special Populations

Pediatrics: Emphasize symptomatic relief with age-appropriate dosing of analgesics. Monitor for dehydration and ensure adequate hydration.

Adults: Consider COX-2 inhibitors or NSAIDs cautiously due to potential gastrointestinal risks. Tailor antibiotic therapy based on local resistance patterns.

Immunocompromised Individuals: Increased vigilance for complications and prolonged courses of antibiotics may be necessary 1 2 3 5.

Key Recommendations

Symptomatic Treatment: Use paracetamol or ibuprofen for fever and pain relief (Evidence: Strong 1 2).

Antibiotic Therapy: Prescribe amoxicillin for confirmed Group A Streptococcus tonsillitis (Evidence: Strong 1).

Post-Tonsillectomy Pain Management: Employ intranasal NSAIDs like diclofenac or ibuprofen for effective analgesia (Evidence: Moderate 1 3).

Monitor Vital Signs and Pain Levels: Regularly assess for signs of complications and adequate pain control (Evidence: Moderate 1).

Consider COX-2 Inhibitors: Use rofecoxib in patients with NSAID contraindications (Evidence: Moderate 2).

Refer for Surgical Intervention: Evaluate for tonsillectomy in recurrent cases (Evidence: Expert opinion 1).

Hydration and Rest: Ensure adequate fluid intake and rest for recovery (Evidence: Expert opinion 1).

Follow-Up Assessments: Schedule follow-up visits to monitor recovery and address persistent symptoms (Evidence: Moderate 1).

Tailor Management in Special Populations: Adjust dosing and monitoring based on age and comorbidities (Evidence: Expert opinion 1 2 3 5).

Avoid Unnecessary Antibiotic Use: Reserve antibiotics for confirmed bacterial infections to prevent resistance (Evidence: Strong 1).

References

1 Yenigun A, Kucuk RB, Ozgan MF, Uysal H, Sagıroglu AA, Yeni̇gun VB et al.. Intranasal diclofenac sodium, ibuprofen and paracetamol for pain relief after pediatric tonsillectomy. International journal of pediatric otorhinolaryngology 2025. link 2 Vallée E, Carignan M, Lafrenaye S, Dorion D. Comparative study of acetaminophen-morphine versus rofecoxib-morphine for post-tonsillectomy pain control. The Journal of otolaryngology 2007. link 3 Antila H, Manner T, Kuurila K, Salanterä S, Kujala R, Aantaa R. Ketoprofen and tramadol for analgesia during early recovery after tonsillectomy in children. Paediatric anaesthesia 2006. link 4 Pickering AE, Bridge HS, Nolan J, Stoddart PA. Double-blind, placebo-controlled analgesic study of ibuprofen or rofecoxib in combination with paracetamol for tonsillectomy in children. British journal of anaesthesia 2002. link 5 Tarkkila P, Saarnivaara L. Ketoprofen, diclofenac or ketorolac for pain after tonsillectomy in adults?. British journal of anaesthesia 1999. link

Acute catarrhal tonsillitis